South Korea Respiratory Care Devices Market Overview, 2031

The market for respiratory devices in South Korea is experiencing quick changes through smart healthcare integration, influenced by the country’s sophisticated ICT framework, robust electronics and medical tech industries, and an increasing incidence of chronic lung diseases. Healthcare providers and innovators are progressively incorporating digital solutions and connected systems into respiratory healthcare to enhance clinical results and foster patient-oriented care models. A significant aspect of the development of respiratory devices in Korea is high levels of R&D activity supported by both government and private entities concentrating on precision sensors, advanced ventilation systems, smart inhalers, and remote monitoring technologies. Research institutions and medical tech startups in Korea are partnering with major tech companies to create AI-driven respiratory tools that assess physiological information in real time and anticipate complications before a clinical decline occurs. For instance, Korean creators are investigating AI-guided control systems for ventilators that automatically modify settings according to the patient’s condition, decreasing the burden on clinicians and enhancing safety in critical care environments. Technical innovations also cover smart inhalers and digital monitoring systems, which utilize Bluetooth connectivity, mobile health applications, and cloud analytics allowing healthcare providers to track usage patterns and compliance beyond conventional care environments. The smart inhalers market in Korea is itself experiencing significant growth, as both patients and healthcare providers are increasingly adopting connected therapeutic devices.

According to the research report, " South Korea Respiratory Devices Market Overview, 2031," published by Bonafide Research, the South Korea Respiratory Devices market was valued at more than USD 396.12 Mllion in 2025. The market for respiratory devices in South Korea has shown consistent growth, reflecting increasing awareness of respiratory health challenges, an aging demographic, and wider technology adoption in medical care. Recent changes in the market highlight innovative therapeutic, diagnostic, and monitoring instruments, such as the growing usage of digital inhalers, portable respirators, and electronic respiratory testing devices. Another notable trend is the rising enthusiasm for AI-powered respiratory monitoring systems, which provide healthcare professionals with immediate information regarding lung function, activity patterns, and early alerts for worsening conditions. These systems utilize machine learning techniques and the combination of sensor data to facilitate proactive management for chronic illnesses such as asthma and COPD. Local startups and research groups are testing systems that can automatically modify ventilator settings or identify declines in lung function, marking a significant improvement from conventional, manually adjusted machines. Major contributors to the South Korean respiratory device market consist of international companies like Philips Healthcare, ResMed alongside local innovators who are concentrating on smart respiratory technologies and comprehensive monitoring solutions. Areas like Seoul, Incheon, and Busan are key centers where research, clinical application, and production come together to foster product development and market introduction. There are numerous chances in AI-supported remote observation, integrated telehealth respiratory treatment, and digital inhalers particularly in home care environments where healthcare providers can track adherence, lung function, and therapy effectiveness outside of medical facilities.

South Korea Respiratory Devices market by product type is divided into therapeutic devices, monitoring devices, diagnostic devices and consumables and accessories. The market for respiratory devices in South Korea, categorized by product types, showcases the country’s state-of-the-art healthcare system, robust local production capabilities, and swift integration of advanced medical technologies. Therapeutic devices represent a significant portion of the market, influenced by the growing incidence of long-term respiratory illnesses and an aging demographic. Devices like ventilators, oxygen concentrators, nebulizers, and positive airway pressure PAP units are commonly utilized in both urgent and ongoing care environments. The South Korea prompted a surge in the local manufacturing of ventilators and oxygen-related devices, which lessened reliance on foreign imports and bolstered internal production abilities. Monitoring devices, such as pulse oximeters, capnographs, and spirometers, are progressively incorporated with digital health ecosystems, showcasing the nation’s advancements in Internet of Things IoT and integrated healthcare methods. These tools are extensively employed for monitoring in both medical facilities and home settings, especially among older adults. Diagnostic devices like systems for pulmonary function tests and equipment for sleep analysis benefit from South Korea’s extensive hospital networks and focus on early detection of illnesses. The access to advanced diagnostic tools in major hospitals aids in precise respiratory evaluations. On the other hand, consumables and accessories, which include masks, breathing circuits, filters, and nasal cannulas, secure a consistent and recurring need due to high usage rates of the devices. The rigorous regulatory framework established by the Ministry of Food and Drug Safety MFDS guarantees quality and safety across all product classifications.

South Korea Respiratory Devices market by end user is divided into hospitals, ambulatory care centers, home care settings and other user. The respiratory devices market in South Korea shows distinct differences among end-user segments, influenced by healthcare models, reimbursement structures, and patient choices. Hospitals continue to be the primary end users, especially large tertiary hospitals and those affiliated with universities, which act as referral centers for complicated respiratory conditions. These medical facilities have advanced ventilators, diagnostic tools, and monitoring equipment, and are essential in handling severe cases of COPD, infectious respiratory diseases, and critical care situations. Ambulatory Care Centers ACCs are gaining prominence, particularly in urban regions, as the country focuses on cost-effective outpatient care and minimized hospital stays. ACCs often use diagnostic and monitoring respiratory devices for early detection, ongoing care, and assessments of sleep disorders. The home care settings segment is among the fastest-growing, propelled by a rising elderly population, a greater burden of chronic illnesses, and a strong digital health infrastructure. Home-based oxygen therapy, CPAP machines, and portable monitoring systems are increasingly receiving reimbursement, encouraging their use among senior and long-term patients. This growth aligns with national initiatives that promote home-centered healthcare to alleviate burden on hospitals. Other end users, such as research organizations, rehabilitation facilities, and military health services, also play a role in market demand, especially for specialized and portable respiratory solutions. South Korea's single-payer National Health Insurance Service NHIS significantly impacts end-user demand by affecting the affordability and access to devices. Ultimately, end-user segmentation underscores a gradual transition from hospital-focused care toward outpatient and home-based respiratory management, backed by robust policies and technologies.

"Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031



Aspects covered in this report
• Respiratory Care Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Therapeutic Devices (Inhalers,Ventilators,Positive Airway Pressure (PAP) Devices,Humidifiers,Nebulizers,Others(Oxygen Concentrators, oxygen Hood))
• Monitoring Devices (Pulse Oximeters,Gas Analyzers,Others)
• Diagnostic Devices (Spirometers,Polysomnography Devices,Peak Flow Meters,Others)
• Consumables and Accessories (Disposable Resuscitators,Breathing Circuits,Masks,Tracheostomy Tubes,Others(Nasal Cannulas))
By Disease Indication
• Chronic Obstructive Pulmonary disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Other disease Indications (Respiratory Distress Syndrome, cystic Fibrosis)

By End User
• Hospitals
• Ambulatory Care Centers (ACCs)
• Home care Settings
• Other End User
"